Foreword |
|
v | |
|
Preface |
|
vii | |
Contributors |
|
xiii | |
|
I. Basic Principles of Chemotherapy |
|
|
|
Antineoplastic Agents: Classification and Mechanisms of Action |
|
|
1 | (12) |
|
|
|
Mechanisms of Chemosensitivity and Resistance |
|
|
13 | (34) |
|
|
|
In Vitro Testing for Drug Sensitivity/Resistance |
|
|
47 | (10) |
|
|
Basic Principles of Dose Intensity and High-Dose Chemotherapy |
|
|
57 | (10) |
|
|
|
|
|
|
Immunotherapy in Gynecologic Malignancies |
|
|
67 | (26) |
|
|
|
Gene Therapy of Ovarian Cancer |
|
|
93 | (26) |
|
|
|
Basic Concepts of Chemotherapy Sequence and Combinations |
|
|
119 | (18) |
|
|
|
Pharmacoeconomic Applications in Gynecologic Oncology |
|
|
137 | (8) |
|
|
II. Clinical Aspects of Chemotherapy |
|
|
|
Guidelines to Writing a Clinical Protocol |
|
|
145 | (28) |
|
|
Evaluation of Gynecologic Tumor Response: When and How? |
|
|
173 | (14) |
|
|
|
Practical Guide on How to Deliver Chemotherapy |
|
|
187 | (14) |
|
|
|
Evaluation of the Patient for Chemotherapy |
|
|
201 | (6) |
|
|
|
|
|
|
Chemotherapy in Pregnancy |
|
|
207 | (26) |
|
Christine H. Holschneider |
|
|
|
|
Supportive Treatment in Gynecologic Malignancies |
|
|
233 | (12) |
|
|
|
|
|
Hormone Replacement Therapy in Gynecologic Cancer Patients and Survivors |
|
|
245 | (12) |
|
|
|
Infections in Patients with Gynecological Malignancies: Prevention and Management |
|
|
257 | (18) |
|
|
|
Pharmacologic Pain Management in Gynecologic Oncology |
|
|
275 | (22) |
|
|
|
|
Blood Transfusion During Chemotherapy: Risks and Benefits |
|
|
297 | (10) |
|
|
|
Role of Tumor Markers in Gynecologic Oncology |
|
|
307 | (10) |
|
|
|
Role of Chemoprotectors During Chemotherapy for Gynecologic Neoplasms |
|
|
317 | (8) |
|
|
|
Chemoprevention in Gynecological Oncology |
|
|
325 | (20) |
|
|
|
Role of Psychological Support During Chemotherapy |
|
|
345 | (10) |
|
Sabine Hawighorst-Knapstein |
|
|
|
|
Quality of Life During Chemotherapy: Recent Results and Methodological Challenges of Conducting Quality-of-Life Studies with Gynecological Cancer Patients |
|
|
355 | (12) |
|
|
|
|
|
|
367 | (12) |
|
|
Pierluigi Benedetti Panici |
|
|
|
|
|
Management of Early Epithelial Ovarian Cancer |
|
|
379 | (12) |
|
|
|
|
Chemotherapy for Advanced Primary Epithelial Ovarian Cancer: Neoadjuvant and Adjuvant |
|
|
391 | (16) |
|
|
Persistent and Recurrent Ovarian Cancer |
|
|
407 | (26) |
|
|
|
Intraperitoneal Chemotherapy: Basic Concepts and Clinical Trials |
|
|
433 | (8) |
|
|
Chemotherapy for Germ Cell Tumors |
|
|
441 | (18) |
|
|
|
Chemotherapy for Sex Cord--Stromal Tumors |
|
|
459 | (12) |
|
|
|
Ovarian Cancer: Rationale and Strategies Beyond First-Line Treatment |
|
|
471 | (12) |
|
|
|
|
|
|
483 | (6) |
|
Pierluigi Benedetti Panici |
|
|
|
|
|
Chemotherapy of Fallopian Tube Cancer |
|
|
489 | (8) |
|
|
|
|
|
|
497 | (10) |
|
|
|
|
Pierluigi Benedetti Panici |
|
|
Medical Therapy for Endometrial Hyperplasia and Early Endometrial Cancer in Patients Desiring Future Childbearing |
|
|
507 | (12) |
|
|
|
Uterine Carcinomas: Chemotherapy for Primary and Recurrent Tumors |
|
|
519 | (10) |
|
|
|
Chemotherapy in Uterine Mesenchymal Tumors |
|
|
529 | (18) |
|
|
|
|
|
|
|
547 | (8) |
|
Pierluigi Benedetti Panici |
|
|
|
|
|
Neoadjuvant Chemotherapy in Cervical Cancer |
|
|
555 | (18) |
|
Pierluigi Benedetti Panici |
|
|
|
Chemoradiation Therapy for Cervical Cancer |
|
|
573 | (16) |
|
|
Chemotherapy for Recurrent and Advanced Cervical Cancer |
|
|
589 | (20) |
|
|
|
|
|
|
609 | (8) |
|
Pierluigi Benedetti Panici |
|
|
|
|
Chemotherapy in Vulvar Cancer |
|
|
617 | (8) |
|
|
|
|
|
625 | (6) |
|
|
|
|
Vaginal Cancer Chemotherapy |
|
|
631 | (6) |
|
|
|
|
VIII. Gestational Trophoblastic Disease |
|
|
|
Management of Hydatidiform Mole |
|
|
637 | (10) |
|
|
|
|
647 | (14) |
|
|
|
|
Rare Tumor: Melanoma---Lymphoma---Sarcoma |
|
|
661 | (12) |
|
|
Index |
|
673 | |